Hypertension Specialist
Core curriculum

Section 1: Definition and classification

Section 2: Epidemiology

Seminars 2001
http://www.eshonline.org/education/archivio/lectures/Bulpitt.htm
C.J. Bulpitt (London, UK); Epidemiology of Hypertension

http://www.eshonline.org/education/newsletter.htm
How Well Is Hypertension Controlled in Europe?; (S. Erdine)
Newsletter 3

a. Prevalence of essential and secondary hypertension

http://www.eshonline.org/education/congresses/2006/esh/teaching_seminars.asp
J. Menard, FR Arterial hypertension and public health

b. Effect of age, gender and ethnicity

http://www.eshonline.org/education/archivio/esh2003/teaching_seminars_2003.htm
R. Cifkowa, Hypertension in women

c. Systolic, diastolic and pulse pressure as cardiovascular risk factors
d. Concomitant risk factors

INTERVIEWS: WORKSHOP 5 Proteinuria and total cv risk
http://www.eshonline.org/education/congresses/2006/esh/14_giu_WKS_5.asp
The kidney, a sensor of a cardiovascular risk and a new target therapy;
D. de Zeeuw

e. Risk factor interactions

INTERVIEWS: WORKSHOP 5 Proteinuria and total cv risk
http://www.eshonline.org/education/congresses/2006/esh/14_giu_WKS_5.asp
Classical and new risk markers for total cardiovascular risk; S.E. Kjeldsen,

Section 3: Aetiology and pathophysiology

a. Secondary hypertension
b. Essential hypertension

http://www.eshonline.org/education/congresses/2006/esh/teaching_seminars.asp
H. Struijker Boudier, NL; Transient prehypertensive treatment and the progression of hypertension

  1. Genetic factors
    http://www.eshonline.org/education/congresses/2006/esh/teaching_seminars.asp
    Thursday, June 15; 2006; A. Dominiczak, UK;  Omics and cardiovascular disease or pathwayomics and cardiovascular disease
  2. Environmental factors
  3. Autonomic abnormalities
  4. Renal functional and structural abnormalities
    Seminars 2001;
    http://www.eshonline.org/education/archivio/lectures/rodicio.htm
    J.L. Rodicio (Madrid, Spain); The Kidney and Arterial Hypertension
  5. The renin-angiotenin-aldosteron system
  6. Endothelial dysfunction
  7. Other humoral-endocrine factors
    Seminars 2001
    http://www.eshonline.org/education/archivio/lectures/mantero.htm
    F. Mantero (Padova, Italy); Endocrine Hypertension
  8. Insulin resistance and other metabolic factors
  9. Cardiovascular structural changes
  10. The multifactorial hypothesis

c. Hemodynamic patterns from early to late and complicated hypertension

http://www.eshonline.org/education/archivio/esh2002/webcourse.htm
HEMODYNAMICS OF HYPERTENSION; Kiowski W

d. The contribution of experimental hypertension models

http://www.eshonline.org/education/archivio/esh2002/webcourse.htm
TRENDS IN HYPERTENSION RESEARCH; Haller H

Section 4: Associated risk factors

a.  Obesity (central and peripheral)

Teaching Session Wednesday, June 26, 2002
http://www.eshonline.org/education/archivio/esh2002/webcourse.htm
OBESITY AND HYPERTENSION; Fagard R

b.  Sleep apnea

http://www.eshonline.org/education/newsletter.htm
Obstructive Sleep Apnea and Hypertension; (J.P. Baguet, K. Narkiewicz and J.M.   Mallion)
Newsletter no 25

c.  Alterations in glucose metabolism

  1. Insulin resistance
  2. Impaired glucose tolerance
  3. Diabetes mellitus

c.  Dyslipidemia
d.  Metabolic syndrome

Monday, June 20; 2005
http://www.eshonline.org/education/congresses/esh_2005/teaching_seminars.asp
Hypertension and the metabolic syndrome, Prof. P.A. van Zwieten

14 June, 2006 WEBCASTS: Topical workshop 3/Proactive Study http://www.eshonline.org/education/congresses/2006/esh/14_giu_WKS_3.asp
Cardiovascular risk management in metabolic syndrome; P. Nilsson;

f.   Hyperuricemia
g.  Others